Viruses and Other Acellular Infectious Agents
Viruses and Other Acellular Infectious Agents
Viruses and Other Acellular Infectious Agents
Viruses and
Other Acellular
Infectious Agents
1
6.1 Viruses
2
Acellular Agents
3
Viruses
• Major cause of disease
– also importance as a new source of therapy
– new viruses are emerging
• Important members of aquatic world
– move organic matter from particulate to
dissolved
• Important in evolution
– transfer genes between bacteria, others
• Important model systems in molecular biology
4
General Properties of Viruses
• Virion
– complete virus particle
– consists of 1 molecule of DNA or RNA
enclosed in coat of protein
– may have additional layers
– cannot reproduce independent of living cells
nor carry out cell division
• but can exist extracellularly
5
Virions Infect All Cell Types
• Bacterial viruses called bacteriophages
(phages)
• Few archaeal viruses
• Most are eukaryotic viruses
– plants, animals, protists, and fungi
• Classified into families based on
– genome structure, life cycle, morphology,
genetic relatedness
6
6.2 Virion structure
7
The Structure of Viruses
• Virion size range is ~10–400 nm in diameter and
most viruses must be viewed with an electron
microscope
• All virions contain a nucleocapsid which is
composed of nucleic acid (DNA or RNA) and a
protein coat (capsid)
– some viruses consist only of a nucleocapsid, others
have additional components
• Envelopes
8
9
Capsids
10
Helical Capsids
• Shaped like hollow tubes with protein walls
• Protomers self assemble
• Size of capsid is a function of nucleic acid
11
12
Icosahedral Capsids
14
15
Viral Envelopes and Enzymes
17
Virion Enzymes
• It was first erroneously thought that all virions
lacked enzymes
• Now accepted that a variety of virions have
enzymes
– some are associated with the envelope or
capsid but most are within the capsid
18
Viral Genome
• Diverse nature of genomes
• A virus may have single or double stranded
DNA or RNA
• The length of the nucleic acid also varies
from virus to virus
• Genomes can be segmented or circular
19
6.3 Viral multiplication
20
Viral Multiplication
• Mechanism used
depends on viral
structure and genome
• Steps are similar
– attachment to host cell
– entry
– uncoating of genome
– synthesis
– assembly
– release
21
Attachment (Adsorption)
22
Viral Entry and Uncoating
• Entire genome or nucleocapsid
• Varies between naked or enveloped virus
• Three methods used
– fusion of the viral envelope with host
membrane; nucleocapsid enters
– endocytosis in vesicle; endosome aids in viral
uncoating
– injection of nucleic acid
23
24
Synthesis Stage
• Genome dictates the events
• ds DNA typical flow
• RNA viruses
– virus must carry in or synthesize the proteins
necessary to complete synthesis
• Stages may occur, e.g., early and late
25
Assembly
• Late proteins are
important in assembly
• Assembly is
complicated but varies
– bacteriophages –
stages
– some are assembled
in nucleus
– some are assembled
in cytoplasm
– may be seen as
paracrystalline
structures in cell
26
Virion Release
• Nonenveloped viruses lyse the host cell
– viral proteins may attack peptidoglycan or
membrane
27
Virion
Release
29
Types of Viral Infections
30
Bacterial and Archaeal Viral
Infections
• Virulent phage – one reproductive choice
– multiplies immediately upon entry
– lyses bacterial host cell
• Temperate phages have two reproductive options
– reproduce lytically as virulent phages do
– remain within host cell without destroying it
• many temperate phages integrate their genome into
host genome (becoming a ‘prophage’ in a ‘lysogenic
bacterium’) in a relationship called lysogeny
31
32
Lysogenic Conversion
• Temperate phage changes phenotype of its host
– bacteria become immune to superinfection
– phage may express pathogenic toxin or enzyme
• Two advantages to lysogeny for virus
– phage remains viable but may not replicate
– multiplicity of infection ensures survival of host cell
• Under appropriate conditions infected bacteria will
lyse and release phage particles
– occurs when conditions in the cell cause the
prophage to initiate synthesis of new phage
particles, a process called induction
33
Archaeal Viruses
34
Infection in Eukaryotic Cells
• Cytocidal infection results in cell death
through lysis
• Persistent infections may last years
• Cytopathic effects (CPEs)
– degenerative changes
– abnormalities
• Transformation to malignant cell
35
36
Viruses and Cancer
• Tumor
– growth or lump of tissue;
– benign tumors remain in place
• Neoplasia
– abnormal new cell growth and reproduction
due to loss of regulation
• Anaplasia
– reversion to a more primitive or less
differentiated state
• Metastasis
– spread of cancerous cells throughout body
37
Carcinogenesis
• Complex, multistep process
• Often involves oncogenes
– cancer causing genes
– may come from the virus OR may be transformed
host proto-oncogenes (involved in normal regulation
of cell growth/differentiation)
38
Possible Mechanisms by Which
Viruses Cause Cancer
• Viral proteins bind host cell tumor suppressor
proteins
• Carry oncogene into cell and insert it into host
genome
• Altered cell regulation
• Insertion of promoter or enhancer next to
cellular oncogene
39
6.5 Cultivation and enumeration of
viruses
1. List the types of approaches used to cultivate viruses,
noting which types of viruses are cultivated by each
method.
2. Describe three direct counting methods and two
indirect counting methods used to enumerate viruses.
3. Outline the events that lead to the formation of a
plaque in a lawn of bacterial cells.
4. Distinguish lethal dose from infectious dose.
40
The Cultivation of Viruses
41
Hosts for Bacterial and Archael
Viruses
• Usually cultivated in broth or agar cultures of
suitable, young, actively growing bacteria
• Broth cultures lose turbidity as viruses
reproduce
• Plaques observed on agar cultures
42
Hosts for Animal Viruses
• Tissue (cell) cultures
– cells are infected with virus (phage)
– viral plaques
• localized area of cellular destruction and lysis that
enlarge as the virus replicates
• Cytopathic effects (CPEs)
– microscopic or macroscopic
degenerative changes or
abnormalities in host
cells and tissues
• Embryonated eggs
43
Hosts for Plant Viruses
• Plant tissue cultures
• Plant protoplast cultures
• Suitable whole plants
– may cause localized
necrotic lesions or
generalized symptoms
of infection
44
Quantification of Virus
• Direct counting – count viral
particles
• Indirect counting by an
observable of the virus
– hemagglutination assay
– plaque assays
45
Measuring Concentration of
Infectious Units
• Plaque assays
– dilutions of virus preparation made and plated
on lawn of host cells
– number of plaques counted
– results expressed as plaque-forming units
(PFU) – plaque forming units (PFU)
• PFU/ml = number of plaques/sample dilution
46
Measuring Biological Effects
• Infectious dose and lethal dose assays
– determine smallest amount of virus needed to cause
infection (ID) or death (LD) of 50% of exposed host
cells or organisms (ID50 or LD50)
47
6.6 Viroids and satellites
48
Viroids
• infectious agents
composed of closed,
circular ssRNAs
• do not encode gene
products
• requires host cell
DNA-dependent RNA
polymerase to
replicate
• cause plant diseases
49
Satellites
• Infectious nucleic acids (DNA or RNA)
– Satellite viruses encode their own capsid
proteins when helped by a helper virus
– Satellite RNAs/DNAs do NOT encode their
own capsid proteins
• Encode one or more gene products
• Require a helper virus for replication
– human hepatitis D virus is satellite
– requires human hepatitis B virus
50
6.7 Prions
51
Prions – Proteinaceous
Infectious Particle
• Cause a variety of degenerative diseases in
humans and animals
– scrapie in sheep
– bovine spongiform encephalopathy (BSE) or
mad cow disease
– Creutzfeldt-Jakob disease (CJD) and variant
CJD (vCJD) in humans
– kuru in humans
52
Current Model of Disease
Production by Prions
• PrPC (prion protein) is present in
“normal” form (abnormal form of
prion protein is PrPSc)
• PrPSc causes PrPC protein to
change its conformation to
abnormal form
• newly produced PrPSc molecules
convert more normal molecules
to the abnormal form through
unknown mechanism 53
Neural Loss
• Evidence suggests that PrPC must be present
for neural degeneration to occur
• Interaction of PrPSc with PrPC may cause PrPC
to crosslink and trigger apoptosis
• PrPC conversion causes neuron loss, PrPSc is
the infectious agent
• All prion caused diseases
– have no effective treatment
– result in progressive degeneration of the brain
and eventual death
54